IRIS
MORAN, EVA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.992
Totale 2.992
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.992
Totale 2.992
Salva come PNG Salva come JPEG
Città #
Genova 2.154
Rapallo 384
Genoa 305
Vado Ligure 147
Bordighera 2
Totale 2.992
Salva come PNG Salva come JPEG
Nome #
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 178
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 177
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 161
APO866 activity in hematologic malignancies: a preclinical in vitro study. 157
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 153
Ras-induced resistance to lapatinib is overcome by MEK inhibition 149
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. 147
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. 147
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 144
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 143
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 138
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 133
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 122
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 121
Immunotherapy with dendritic cells for cancer 118
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 110
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 107
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 100
Catastrophic NAD+ Depletion through Nampt Inhibition in Activated T Lymphocytes Reduces Demyelination and Disability in EAE. 98
Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 89
Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma. 77
The role of proteasome in malignant diseases. 67
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 63
Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis 63
Selection of patients with high risk endometrial cancer for surgical staging according to the evaluation of pre- and intraoperative risk factors 53
Totale 3.015
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.926
article - articoli 8.655
book - libri 0
conference - conferenze 271
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.852
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020544 0 0 0 0 62 78 98 41 48 111 84 22
2020/2021184 16 15 9 14 27 16 14 13 14 13 15 18
2021/2022360 14 29 37 54 16 16 23 78 8 32 19 34
2022/2023468 44 59 2 60 99 56 7 25 55 1 54 6
2023/2024208 5 15 3 31 13 64 11 8 7 2 15 34
2024/2025162 22 40 10 50 40 0 0 0 0 0 0 0
Totale 3.015